C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2002
10/30/2002	CN1376705A Polypeptide-human macro protein -34.98 and polynucleotide for coding it
10/30/2002	CN1376704A Polypeptide-human macro protein -24.97 and polynucelotide for coding it
10/30/2002	CN1376703A Polypeptide-human macro protein -19.14 and polynucleotide for coding it
10/30/2002	CN1376702A Polypeptide-human macro protein -62.59 and polynucleotide for coding it
10/30/2002	CN1376701A Polypeptide-human nucleic 20.24 and polynucleotide for coding it
10/30/2002	CN1376700A Polypeptide-human macro protein -57.75 and polynucleotide for coding it
10/30/2002	CN1376699A Polypeptide-human zinc finger -62.70 and polynucleotide for coding it
10/30/2002	CN1376698A Polypeptide-human zinc finger protein -57.21 and polynucleotide for coding it
10/30/2002	CN1376697A Polypeptide-human zinc finger protein 47.17 and polynucleotide for coding it
10/30/2002	CN1376696A Polypeptide-secretory protein -38.17 and polynucleotide for coding it
10/30/2002	CN1376695A Polypeptide-human transducin-22.88 and polynucleotide for coding it
10/30/2002	CN1376694A Polypeptide-human ring finger protein-15.18 and polynucleotide for coding it
10/30/2002	CN1376693A Polypeptide-human liposecretion protein-27.06 and polynucleotide for coding it
10/30/2002	CN1376692A Polypeptide-immunologlobulin light chain K1 protein -26.07 and polynucleotide for coding it
10/30/2002	CN1376691A Polypeptide-olfactory receptor protein-14.3 and polynucleotide for coding it
10/30/2002	CN1376690A Polypeptide-Na ion efferent protein-20.13 and polynucleotide for coding it
10/30/2002	CN1376689A Polypeptide-human myelin development regulation protein-21.78 and polynucleotide for coding it
10/30/2002	CN1376688A Polypeptide-human eye development regulation protein -47.63 and polynucleotide for coding it
10/30/2002	CN1376687A Polypeptide-human ankyrin-56.21 and polynucleotide for coding it
10/30/2002	CN1376686A Polypeptide-indenture protein-34.32 and polynucleotide for coding it
10/30/2002	CN1376685A Polypeptide-zinc finger protein -65.23 and polynucleotide for coding it
10/30/2002	CN1376684A Polypeptide-paneth cell expression enhancing protein-43.78 and polynucleotide for coding it
10/30/2002	CN1376683A Polypeptide-human zinc finger protein 33.22 and polynucleotide for coding it
10/30/2002	CN1376682A Polypeptide-human member protein-47.96 and polynucleotide for coding it
10/30/2002	CN1376681A Polypeptide-human zinc finger protein-18.81 and polynucleotide for coding it
10/30/2002	CN1376680A Polypeptide-human fusion protein-19.8 and polynucleotide for coding it
10/30/2002	CN1376679A Polypeptide-ankyrine-similar protein-77.77 and polynucleotide for coding it
10/29/2002	US6472587 Production of a 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid or 7-chloro-3-methyllquinoline-8-carboxylic acid-tolerant plant by expressing an exogenous 5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitrobenzoic acid or 7-chloro-3-methyllquinoline-8-carboxylic acid-binding antibody in the plant
10/29/2002	US6472585 Cardiotrophin-1 defective mouse
10/29/2002	US6472516 Progestin-regulated gene
10/29/2002	US6472511 Stimulation of an immune response with antibodies labeled with the α-galactosyl epitope
10/29/2002	US6472510 CD40 receptor ligands
10/29/2002	US6472368 Compounds and methods for modulating adhesion molecule function
10/29/2002	US6472367 Compounds and methods for modulating OB-cadherin mediated cell adhesion
10/29/2002	US6472211 Amplification of transcription of preferential genes; obtain cell, incubate with regulatory protein, monitor propagation of cells
10/29/2002	US6472197 GRB2 associating polypeptides and nucleic acids encoding therefor
10/29/2002	US6472195 Human kallikrein
10/29/2002	US6472174 Polypeptides bind to the hek or elk receptor, the nucleic acids encoding such polypeptides; genetic engineering
10/29/2002	US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002	US6472150 Determining molecules that kill arthropods or reduce the ability of their vectors to transmit pathogens by allowing groups to feed on them and recovering biomolecules from detectably affected individuals
10/29/2002	US6472143 Determining the amount of the complex in a sample and correlating the amount to the presence or absence of a tumor
10/29/2002	US6471964 Designated as structural protein-1 (sp-1), the isolated sp-1 protein, and use of the nucleic acid and/or protein for diagnostic or vaccine purposes
10/29/2002	US6471962 Monoclonal antibodies for infectious bursal disease, vaccines and assays for use therewith
10/29/2002	US6471961 Interleukin antagonists for the treatment of neurological, retinal and muscular disorders
10/29/2002	US6471959 Human transferase
10/29/2002	US6471957 Canine IL-4 immunoregulatory proteins and uses thereof
10/29/2002	US6471956 Ob polypeptides, modified forms and compositions thereto
10/29/2002	EP0960196A4 Novel receptor that causes cell death
10/29/2002	CA2221242C Viral agent associated with mystery swine disease
10/29/2002	CA2173102C Dna sequence coding for a bmp receptor
10/29/2002	CA2090515C Anti-feline calicivirus recombinant antibody and gene fragment encoding the same
10/29/2002	CA2063431C Receptors for fibroblast growth factors
10/29/2002	CA2045552C Cancer related haptoglobin
10/24/2002	WO2002084294A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections
10/24/2002	WO2002084277A1 Structure-based construction of human antibody library
10/24/2002	WO2002083929A2 System and method for quantitating transcription factors
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002	WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	WO2002083874A2 Endothelial cell expression patterns
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083872A2 Methods and products of cleaving ssdna using oligonucleotides to form restriction sites
10/24/2002	WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002	WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002	WO2002083859A2 Surface proteins of streptococcus pyogenes
10/24/2002	WO2002083858A2 Methods to inhibit viral replication
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083854A2 Antibodies to vla-1
10/24/2002	WO2002083853A2 Method for enhancing the translation and expression of recombinant proteins
10/24/2002	WO2002083850A2 Vascular endothelial growth factor 2
10/24/2002	WO2002083849A2 Vascular endothelial growth factor 2
10/24/2002	WO2002083847A2 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/24/2002	WO2002083843A2 Outer membrane associated polypeptides
10/24/2002	WO2002083738A1 Cyclic single strand trispecific antibody
10/24/2002	WO2002083737A1 Anti pilyrosporum ovale lgy and its uses
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083717A1 Induction of spawning in crustacea
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083711A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083707A1 Tub antisense constructs
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083172A1 Methods for inhibiting hiv-1 infection
10/24/2002	WO2002083171A2 Cancer treatment by using fap-alpha specific antibodies
10/24/2002	WO2002083162A1 Use of a cd8+ t cell inhibitory agent in the presence of a cd4+ t cell inhibitory agent for inhibition of transplant rejection
10/24/2002	WO2002083160A2 Agents, which inhibit apoptosis in cells that are involved in wound healing
10/24/2002	WO2002083068A2 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
10/24/2002	WO2002083030A2 Bifunctional energy-reversible acyl-compositions
10/24/2002	WO2002064746A3 Combined transductional and transcriptional targeting system for improved gene delivery
10/24/2002	WO2002058714A3 Methods and agents modulating upa/upar activity
10/24/2002	WO2002022777A3 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
10/24/2002	WO2001073052A3 Thermophilic polymerase iii holoenzyme
10/24/2002	WO2001062793A9 Estrogen receptor beta variants and methods of detection thereof
10/24/2002	WO2001058526A9 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides

1 ... 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 ... 1494